Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design

被引：9

作者：

Freeman, Zachary T. ^{[1
]}

Cox, Andrea L. ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA

来源：

PLOS PATHOGENS | 2016年 / 12卷 / 06期

关键词：

HEPATITIS-C-VIRUS; INFECTION; CLEARANCE; RESPONSES; CHIMPANZEES; REPLICATION; REINFECTION; PERSISTENCE; RECHALLENGE; PROTECTION;

D O I：

10.1371/journal.ppat.1005632

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

[No abstract available]

引用

页数：6

共 36 条

[1] Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection [J].

Bassett, SE ;

Guerra, B ;

Brasky, K ;

Miskovsky, E ;

Houghton, M ;

Klimpel, GR ;

Lanford, RE .

HEPATOLOGY, 2001, 33 (06) :1479-1487

[2] Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection [J].

Chang, KM ;

Thimme, R ;

Melpolder, JJ ;

Oldach, D ;

Pemberton, J ;

Moorhead-Loudis, J ;

McHutchison, JG ;

Alter, HJ ;

Chisari, FV .

HEPATOLOGY, 2001, 33 (01) :267-276

[3] VACCINATION OF CHIMPANZEES AGAINST INFECTION BY THE HEPATITIS-C VIRUS [J].

CHOO, QL ;

KUO, G ;

RALSTON, R ;

WEINER, A ;

CHIEN, D ;

VANNEST, G ;

HAN, J ;

BERGER, K ;

THUDIUM, K ;

KUO, C ;

KANSOPON, J ;

MCFARLAND, J ;

TABRIZI, A ;

CHING, K ;

MOSS, B ;

CUMMINS, LB ;

HOUGHTON, M ;

MUCHMORE, E .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1294-1298

[4]

Christie JML, 1997, CLIN EXP IMMUNOL, V110, P4

[5] Cellular immune selection with hepatitis C virus persistence in humans [J].

Cox, AL ;

Mosbruger, T ;

Mao, Q ;

Liu, Z ;

Wang, XH ;

Yang, HC ;

Sidney, J ;

Sette, A ;

Pardoll, D ;

Thomas, DL ;

Ray, SC .

JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (11) :1741-1752

[6] Global control of hepatitis C virus A comprehensive strategy to control HCV infection must include a vaccine [J].

Cox, Andrea L. .

SCIENCE, 2015, 349 (6250) :790-791

[7] A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients [J].

Davis, GL ;

Nelson, DR ;

Terrault, N ;

Pruett, TL ;

Schiano, TD ;

Fletcher, CV ;

Sapan, CV ;

Riser, LN ;

Li, YF ;

Whitley, RJ ;

Gnann, JW .

LIVER TRANSPLANTATION, 2005, 11 (08) :941-949

[8] Broadly neutralizing antibodies abrogate established hepatitis C virus infection [J].

de Jong, Ype P. ;

Dorner, Marcus ;

Mommersteeg, Michiel C. ;

Xiao, Jing W. ;

Balazs, Alejandro B. ;

Robbins, Justin B. ;

Winer, Benjamin Y. ;

Gerges, Sherif ;

Vega, Kevin ;

Labitt, Rachael N. ;

Donovan, Bridget M. ;

Giang, Erick ;

Krishnan, Anuradha ;

Chiriboga, Luis ;

Charlton, Michael R. ;

Burton, Dennis R. ;

Baltimore, David ;

Law, Mansun ;

Rice, Charles M. ;

Ploss, Alexander .

SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (254)

[9] The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C [J].

Diepolder, HM ;

Zachoval, R ;

Hoffmann, RM ;

Jung, MC ;

Gerlach, T ;

Pape, GR .

JOURNAL OF MOLECULAR MEDICINE-JMM, 1996, 74 (10) :583-588

[10] Rates of evolutionary change in viruses: patterns and determinants [J].

Duffy, Siobain ;

Shackelton, Laura A. ;

Holmes, Edward C. .

NATURE REVIEWS GENETICS, 2008, 9 (04) :267-276

← 1 2 3 4 →